Takeda Pharmaceutical TAK
NYSE TAK
$20.08 +0.47 (+2.37%)
As of: Oct 20, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Notes Payables (2017 - 2018)

Updated

Takeda Pharmaceutical's Notes Payables came in at $3.34 billion for the year ended Dec 31, 2018, up 19.7% from $2.79 billion a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Notes Payables (2017 - 2018) Analysis & Trends

  • Per Business Quant, earlier years put Notes Payables at $2.79 billion in the year ended Dec 31, 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Takeda Pharmaceutical 63.21 Bn 39.57 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 3.34 Bn
Dec 31, 2017 2.79 Bn
API Access

Takeda Pharmaceutical Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TAK&period=max&api_key=YOUR_API_KEY